Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1140 | 1032 | 1244 | 1246 | 1665 | 3038 |
Fund Return | 14.04% | 3.16% | 24.36% | 7.61% | 10.73% | 11.75% |
Place in category | 1370 | 1452 | 1159 | 686 | 427 | 52 |
% in Category | 81 | 81 | 70 | 48 | 38 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Renaissance Global Growth | 4.66B | 12.93 | 6.23 | 10.30 | ||
Renaissance International Equity | 1.87B | 10.78 | 2.16 | 7.41 | ||
Renaissance International Equity Cl | 1.87B | 11.85 | 3.49 | 8.87 | ||
Renaissance US Equity Income F Pr | 1.48B | 16.62 | 9.57 | 10.88 | ||
Renaissance US Equity Income Fund | 1.48B | 15.51 | 8.19 | 9.41 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators F USD | 8.17B | 39.47 | 14.15 | - | ||
Capital Group Global Equity Fd D | 13.53B | 21.09 | 4.16 | 11.15 | ||
Capital Group Global Equity Fd F | 13.53B | 21.37 | 4.51 | 11.63 | ||
Capital Group Global Equity Fd A | 13.53B | 20.38 | 3.36 | 10.40 | ||
Mackenzie Global Dividend Fund A | 6.94B | 18.38 | 8.79 | 10.33 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.46 | 739.3 | -1.77% | |
Microsoft | US5949181045 | 4.19 | 408.46 | -0.47% | |
Taiwan Semiconductor | US8740391003 | 3.97 | 191.56 | -0.72% | |
Amphenol | US0320951017 | 3.49 | 68.22 | +0.53% | |
Linde PLC | IE000S9YS762 | 2.82 | 420.400 | -0.14% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Strong Buy |
Technical Indicators | Strong Sell | BUY | Strong Buy |
Summary | Strong Sell | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review